MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. (Q38424507)
Jump to navigation
Jump to search
scientific article published on 20 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. |
scientific article published on 20 October 2008 |
Statements
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma (English)
J Sadones
A Michotte
P Veld
R Sciot
J Menten
E J R Joossens
T Strauven
L A D'Hondt
D Sartenaer
S F E H Califice
K Bierau
C Svensson
20 October 2008